Virtu Financial LLC Cns Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$0.19 - $292.65 $9,549 - $14.7 Million	-50,262 Reduced 28.21%	127,922 $23,000
Q2 2022 Aug 09, 2022	BUY	$0.26 - $0.43 $17,273 - $28,567	66,435 Added 59.45%	178,184 $50,000
Q1 2022 May 17, 2022	BUY	$0.26 - $1.05 $29,054 - $117,336	111,749 New	111,749 $38,000
Q4 2021 Feb 17, 2022	SELL	$0.7 - $1.54 $15,735 - $34,619	-22,480 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$1.4 - $1.98 $2,429 - $3,435	1,735 Added 8.36%	22,480 $33,000
Q2 2021 Sep 17, 2021	SELL	$1.71 - $2.42 $35,166 - $49,767	-20,565 Reduced 49.78%	20,745 $41,000
Q1 2021 May 19, 2021	BUY	$1.72 - $4.18 $71,053 - $172,675	41,310 New	41,310 $99,000

100

Ticker CNSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,032,500
Market Cap $4.4M
Description
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme....

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.